News & Updates

New drug applications approved by US FDA as of 16-31 January 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Children conceived by their parents through non-in vitro fertilization fertility treatment show no metabolic difference from those conceived spontaneously, according to a study.

Treatment with sodium-glucose cotransporter 2 (SGLT2) inhibitors appears to have the added benefit of reducing the incidence of obstructive airway disease (OAD) in Asian patients with type 2 diabetes (T2D), as shown in a study from Hong Kong.

Childhood cancer survivors (CCS) appear to have an increased risk of low bone mineral density (BMD) and fracture compared with the general population, according to a cross-sectional study from the Netherlands.

Use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in combination with multiple daily insulin injections (MDII) is associated with an improvement in A1c and a reduction in insulin doses without increased hypoglycaemia, reports a study.

The frequency of meals, rather than the timing, is a stronger determinant of long-term weight change, a study has found.